Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Hepatitis C

Free Subscription Articles published in Proc Natl Acad Sci U S A Retrieve available abstracts of 20 articles: HTML format Text format

Single Articles

April 2019
1. PRENTOE J, Velazquez-Moctezuma R, Augestad EH, Galli A, et al
   Hypervariable region 1 and N-linked glycans of hepatitis C regulate virion neutralization by modulating envelope conformations.
   Proc Natl Acad Sci U S A. 2019 Apr 30. pii: 1822002116.
   PubMed     Text format     Abstract available
   
   
   January 2019
2. WILSON DJ
   The harmonic mean p-value for combining dependent tests.
   Proc Natl Acad Sci U S A. 2019;116:1195-1200.
   PubMed     Text format     Abstract available
   
   
   
3. PETHE MA, Rubenstein AB, Khare SD
   Data-driven supervised learning of a viral protease specificity landscape from deep sequencing and molecular simulations.
   Proc Natl Acad Sci U S A. 2019;116:168-176.
   PubMed     Text format     Abstract available
   
   
   December 2018
4. FURUSE Y
   Analysis of research intensity on infectious disease by disease burden reveals which infectious diseases are neglected by researchers.
   Proc Natl Acad Sci U S A. 2018 Dec 31. pii: 1814484116.
   PubMed     Text format     Abstract available
   
   
   July 2018
5. KINCAID RP, Lam VL, Chirayil RP, Randall G, et al
   RNA triphosphatase DUSP11 enables exonuclease XRN-mediated restriction of hepatitis C virus.
   Proc Natl Acad Sci U S A. 2018 Jul 23. pii: 1802326115.
   PubMed     Text format     Abstract available
   
   
   
6. KE R, Li H, Wang S, Ding W, et al
   Superinfection and cure of infected cells as mechanisms for hepatitis C virus adaptation and persistence.
   Proc Natl Acad Sci U S A. 2018 Jul 9. pii: 1805267115.
   PubMed     Text format     Abstract available
   
   
   June 2018
7. ALEMAN F, Tzarum N, Kong L, Nagy K, et al
   Immunogenetic and structural analysis of a class of HCV broadly neutralizing antibodies and their precursors.
   Proc Natl Acad Sci U S A. 2018 Jun 28. pii: 1802378115.
   PubMed     Text format     Abstract available
   
   
   December 2017
8. MANKOWSKI MC, Kinchen VJ, Wasilewski LN, Flyak AI, et al
   Synergistic anti-HCV broadly neutralizing human monoclonal antibodies with independent mechanisms.
   Proc Natl Acad Sci U S A. 2017 Dec 18. pii: 1718441115.
   PubMed     Text format     Abstract available
   
   
   
9. 
   Correction for Giang et al., Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus.
   Proc Natl Acad Sci U S A. 2017 Dec 11. pii: 1720228115.
   PubMed     Text format    
   
   
   November 2017
10. HIRANO J, Okamoto T, Sugiyama Y, Suzuki T, et al
    Characterization of SPP inhibitors suppressing propagation of HCV and protozoa.
    Proc Natl Acad Sci U S A. 2017 Nov 29. pii: 1712484114.
    PubMed     Text format     Abstract available
    
    
    May 2017
11. PADMANABHAN P, Dixit NM
    Inhibitors of hepatitis C virus entry may be potent ingredients of optimal drug combinations.
    Proc Natl Acad Sci U S A. 2017 May 16. pii: 201704531.
    PubMed     Text format    
    
    
    
12. OHASHI H, Koizumi Y, Fukano K, Wakita T, et al
    Reply to Padmanabhan and Dixit: Hepatitis C virus entry inhibitors for optimally boosting direct-acting antiviral-based treatments.
    Proc Natl Acad Sci U S A. 2017 May 16. pii: 201705234.
    PubMed     Text format    
    
    
    April 2017
13. HANSEN MD, Johnsen IB, Stiberg KA, Sherstova T, et al
    Hepatitis C virus triggers Golgi fragmentation and autophagy through the immunity-related GTPase M.
    Proc Natl Acad Sci U S A. 2017 Apr 7. pii: 201616683.
    PubMed     Text format     Abstract available
    
    
    March 2017
14. 
    Correction for Koizumi et al., Quantifying antiviral activity optimizes drug combinations against hepatitis C virus infection.
    Proc Natl Acad Sci U S A. 2017 Mar 6. pii: 201702625.
    PubMed     Text format    
    
    
    February 2017
15. KOIZUMI Y, Ohashi H, Nakajima S, Tanaka Y, et al
    Quantifying antiviral activity optimizes drug combinations against hepatitis C virus infection.
    Proc Natl Acad Sci U S A. 2017 Feb 7. pii: 201610197.
    PubMed     Text format     Abstract available
    
    
    
16. QI H, Chu V, Wu NC, Chen Z, et al
    Systematic identification of anti-interferon function on hepatitis C virus genome reveals p7 as an immune evasion protein.
    Proc Natl Acad Sci U S A. 2017 Feb 3. pii: 201614623.
    PubMed     Text format     Abstract available
    
    
    December 2016
17. LIU WL, Yang HC, Hsu CS, Wang CC, et al
    Pegylated IFN-alpha suppresses hepatitis C virus by promoting the DAPK-mTOR pathway.
    Proc Natl Acad Sci U S A. 2016 Dec 6. pii: 201618517.
    PubMed     Text format     Abstract available
    
    
    October 2016
18. PIERCE BG, Keck ZY, Lau P, Fauvelle C, et al
    Global mapping of antibody recognition of the hepatitis C virus E2 glycoprotein: Implications for vaccine design.
    Proc Natl Acad Sci U S A. 2016 Oct 26. pii: 201614942.
    PubMed     Text format     Abstract available
    
    
    
19. KONG L, Lee DE, Kadam RU, Liu T, et al
    Structural flexibility at a major conserved antibody target on hepatitis C virus E2 antigen.
    Proc Natl Acad Sci U S A. 2016 Oct 24. pii: 201609780.
    PubMed     Text format     Abstract available
    
    
    
20. WOZNIAK AL, Long A, Jones-Jamtgaard KN, Weinman SA, et al
    Hepatitis C virus promotes virion secretion through cleavage of the Rab7 adaptor protein RILP.
    Proc Natl Acad Sci U S A. 2016 Oct 17. pii: 201607277.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis C is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: